Imatinib mesylate (Gleevec
Casi el 33% de los canadienses (10,6 millones de personas) padecan obesidad en 2023, segn un estudio reciente
For those not familiar, these are injectable medications, taken in a similar way to insulin
The 1.5 mg starter dose of the pill costs $149 a month for patients who pay cash, as part of a recent deal Novo Nordisk made with the Trump administration
"We know there are people who are interested in addressing their weight but have been waiting on the sidelines for a medicine that was right for them." "For many of them, that wait is over as we can now offer the powerful efficacy of Wegovy in a once-daily pill that demonstrated about 17% weight loss, if all patients stayed on treatment," said Ed Cinca, Senior Vice President, Marketing & Patient Solutions at Novo Nordisk
CNBC also reports that a study found that, now that Wegovy is approved to treat heart disease in obese patients, more than 3 million Americans on Medicare could be eligible for prescription coverage of these drugs, noting that the programs budget could be strained as Wegovy is now covered by their Part D prescription plan
